Influence of Screen Sizes on Responses to Visual Analog Scales of Stress (SIVAStress)

February 11, 2026 updated by: University Hospital, Clermont-Ferrand
Visual analog scales (VAS) are one of the most common tools used in questionnaires. VAS are validated for pain and stress for example on a horizontal, non-calibrated line of 100 mm, ranging from very low (0) to very high (100). Nowadays, most VAS are used on questionnaires on internet. However, the influence of screen sizes on responses to visual analog scales were never studied.

Study Overview

Detailed Description

Visual analog scales (VAS) are one of the most common tools used in questionnaires. VAS are validated for pain and stress for example on a horizontal, non-calibrated line of 100 mm, ranging from very low (0) to very high (100). Nowadays, most VAS are used on questionnaires on internet. However, the influence of screen sizes on responses to visual analog scales were never studied.

Primary objective is to study the influence of screen sizes on response responses to visual analog scales.

Secondary objectives are to assess:

  • the variability of responses depending on screen sizes within a week
  • the influence of perception of work and addiction to work on the variability depending on screen sizes
  • relationships with biomarkers of stress : salivary DHEAS, heart rate variability and skin conductance

An open questionnaire will be created by the Clinical Research Direction. The questionnaire will be opened by the examinator who will fulfill the anonymized identification of participants and the type of screens. In a dedicated room at the LaPSCo, the participants will answer the same VAS on four different sizes/types of screens (24-inch screen, laptop, tablet, smartphone) and on paper. Saliva will be collected after answering questionnaires. Heart rate variability and skin conductance will be measured with the use of a wrist watch during 15 minutes, from the entrance in the room to the completion of questionnaires.

The participant will undergo the same examination within a week (15 minutes).

Study Type

Observational

Enrollment (Estimated)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

healhy volunteers

Description

Inclusion Criteria:

  • Adult persons

Exclusion Criteria:

  • Refusal to participate in the study
  • Unable to answer basic questions (difficulties understanding, cognitive disorders…)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
experimental group
differences in responses to visual analog scales depending on screen sizes

An open questionnaire will be created by the Clinical Research Direction. The questionnaire will be opened by the examinator who will fulfill the anonymized identification of participants and the type of screens. In a dedicated room at the LaPSCo, the participants will answer the same VAS on four different sizes/types of screens (24-inch screen, laptop, tablet, smartphone) and on paper. Saliva will be collected after answering questionnaires. Heart rate variability and skin conductance will be measured with the use of a wrist watch during 15 minutes, from the entrance in the room to the completion of questionnaires.

The participant will undergo the same examination within a week (15 minutes).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual analog scale to assess the perceived stress
Time Frame: day 0
Visual analog scale to assess the perceived stress on a horizontal, non-calibrated line of 100 mm, ranging from very low (0) to very high (100)
day 0
Visual analog scale to assess the perceived stress
Time Frame: day 7
Visual analog scale to assess the perceived stress on a horizontal, non-calibrated line of 100 mm, ranging from very low (0) to very high (100)
day 7

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual analog scale to assess anxiety
Time Frame: day 0, day 7
Visual analog scale to assess anxiety on a horizontal, non-calibrated line of 100 mm, ranging from very low (0) to very high (100)
day 0, day 7
Visual analog scale to assess sleep quality
Time Frame: day 0, day 7
Visual analog scale to assess sleep quality on a horizontal, non-calibrated line of 100 mm, ranging from very low (0) to very high (100)
day 0, day 7
Visual analog scale to assess fatigue
Time Frame: day 0, day 7
Visual analog scale to assess fatigue on a horizontal, non-calibrated line of 100 mm, ranging from very low (0) to very high (100)
day 0, day 7
Job Demand-Control-Support (JDSC) questionnaire of Karasek
Time Frame: day 0, day 7
The Job Demand-Control-Support (JDSC) questionnaire of Karasek assessed job demands, job control and social support through 26 items.
day 0, day 7
The Effort-Reward Imbalance Questionnaire (ERI)
Time Frame: day 0, day 7
The Effort-Reward Imbalance Questionnaire (ERI) is a self-administrated test assessing psychological distress and health problems that may occur when there is an imbalance between the efforts required by the work and the rewards received.
day 0, day 7
The Work Addiction Risk Test (WART)
Time Frame: day 0, day 7
The Work Addiction Risk Test (WART) was developed by Robinson et al. from symptoms reported by clinicians caring for patients with work addiction
day 0, day 7
Hospital Anxiety and Depression (HAD) Scale
Time Frame: day 0, day 7
Hospital Anxiety and Depression (HAD) Scale is a self-reported questionnaire composed of 14 items with a 4-point Likert scale assessing anxiety (7 items) and/or depressive (7 items) symptoms
day 0, day 7
The Maslach Burn-out Inventory (MBI)
Time Frame: day 0, day 7
The Maslach Burn-out Inventory (MBI) is composed of 22 items designed to assess the three components of the burn-out syndrome: emotional exhaustion (9 items), depersonalization (5 items) and reduced personal accomplishment (8 items)
day 0, day 7
Heart rate variability
Time Frame: day 0, day 7
Heart rate variability and skin conductance will be measured with the use of the wristband Empatica E4, Italy
day 0, day 7
: skin conductance
Time Frame: day 0, day 7
Heart rate variability and skin conductance will be measured with the use of the wristband Empatica E4, Italy
day 0, day 7
Salivary DHEAS
Time Frame: day 0, day 7
Salivary DHEAS is a biomarker of chronic stress, with a long half-life of 16 hours
day 0, day 7

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: frédéric Dutheil, University Hospital, Clermont-Ferrand

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 2, 2021

Primary Completion (Estimated)

March 1, 2028

Study Completion (Estimated)

March 1, 2028

Study Registration Dates

First Submitted

July 26, 2019

First Submitted That Met QC Criteria

July 30, 2019

First Posted (Actual)

July 31, 2019

Study Record Updates

Last Update Posted (Actual)

February 12, 2026

Last Update Submitted That Met QC Criteria

February 11, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • RNI 2018 DUTHEIL 3
  • 2018-A03280-55 (Other Identifier: 2018-A03280-55)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Volunteers

Clinical Trials on Influence of screen sizes on responses to visual analog scales of stress

Subscribe